IBDEI0SJ ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14059,1,5,0)
 ;;=5^V70.5
 ;;^UTILITY(U,$J,358.3,14059,2)
 ;;=^295595
 ;;^UTILITY(U,$J,358.3,14060,0)
 ;;=585.4^^85^875^14
 ;;^UTILITY(U,$J,358.3,14060,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14060,1,4,0)
 ;;=4^Chr Kidney Dis Stage IV
 ;;^UTILITY(U,$J,358.3,14060,1,5,0)
 ;;=5^585.4
 ;;^UTILITY(U,$J,358.3,14060,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,14061,0)
 ;;=202.80^^85^875^39
 ;;^UTILITY(U,$J,358.3,14061,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14061,1,4,0)
 ;;=4^Lymphoma NEC Unspec Site
 ;;^UTILITY(U,$J,358.3,14061,1,5,0)
 ;;=5^202.80
 ;;^UTILITY(U,$J,358.3,14061,2)
 ;;=^87701
 ;;^UTILITY(U,$J,358.3,14062,0)
 ;;=782.2^^85^875^38
 ;;^UTILITY(U,$J,358.3,14062,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14062,1,4,0)
 ;;=4^Local Suprficial Swellng
 ;;^UTILITY(U,$J,358.3,14062,1,5,0)
 ;;=5^782.2
 ;;^UTILITY(U,$J,358.3,14062,2)
 ;;=^71690
 ;;^UTILITY(U,$J,358.3,14063,0)
 ;;=401.9^^85^875^33
 ;;^UTILITY(U,$J,358.3,14063,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14063,1,4,0)
 ;;=4^Hypertension NOS
 ;;^UTILITY(U,$J,358.3,14063,1,5,0)
 ;;=5^401.9
 ;;^UTILITY(U,$J,358.3,14063,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,14064,0)
 ;;=355.9^^85^875^42
 ;;^UTILITY(U,$J,358.3,14064,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14064,1,4,0)
 ;;=4^Mononeuritis NOS
 ;;^UTILITY(U,$J,358.3,14064,1,5,0)
 ;;=5^355.9
 ;;^UTILITY(U,$J,358.3,14064,2)
 ;;=^78915
 ;;^UTILITY(U,$J,358.3,14065,0)
 ;;=171.9^^85^875^40
 ;;^UTILITY(U,$J,358.3,14065,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14065,1,4,0)
 ;;=4^Mal Neo Soft Tissue NOS
 ;;^UTILITY(U,$J,358.3,14065,1,5,0)
 ;;=5^171.9
 ;;^UTILITY(U,$J,358.3,14065,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,14066,0)
 ;;=117.9^^85^875^43
 ;;^UTILITY(U,$J,358.3,14066,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14066,1,4,0)
 ;;=4^Mycoses NEC/NOS
 ;;^UTILITY(U,$J,358.3,14066,1,5,0)
 ;;=5^117.9
 ;;^UTILITY(U,$J,358.3,14066,2)
 ;;=^87308
 ;;^UTILITY(U,$J,358.3,14067,0)
 ;;=415.19^^85^875^47
 ;;^UTILITY(U,$J,358.3,14067,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14067,1,4,0)
 ;;=4^Pulm Emb & Infarc
 ;;^UTILITY(U,$J,358.3,14067,1,5,0)
 ;;=5^415.19
 ;;^UTILITY(U,$J,358.3,14067,2)
 ;;=^303285
 ;;^UTILITY(U,$J,358.3,14068,0)
 ;;=780.60^^85^875^22
 ;;^UTILITY(U,$J,358.3,14068,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14068,1,4,0)
 ;;=4^Fever NOS
 ;;^UTILITY(U,$J,358.3,14068,1,5,0)
 ;;=5^780.60
 ;;^UTILITY(U,$J,358.3,14068,2)
 ;;=^336764
 ;;^UTILITY(U,$J,358.3,14069,0)
 ;;=787.20^^85^875^21
 ;;^UTILITY(U,$J,358.3,14069,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14069,1,4,0)
 ;;=4^Dysphagia NOS
 ;;^UTILITY(U,$J,358.3,14069,1,5,0)
 ;;=5^787.20
 ;;^UTILITY(U,$J,358.3,14069,2)
 ;;=^335307
 ;;^UTILITY(U,$J,358.3,14070,0)
 ;;=786.30^^85^875^30
 ;;^UTILITY(U,$J,358.3,14070,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14070,1,4,0)
 ;;=4^Hemoptysis NOS
 ;;^UTILITY(U,$J,358.3,14070,1,5,0)
 ;;=5^786.30
 ;;^UTILITY(U,$J,358.3,14070,2)
 ;;=^339669
 ;;^UTILITY(U,$J,358.3,14071,0)
 ;;=787.60^^85^875^36
 ;;^UTILITY(U,$J,358.3,14071,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14071,1,4,0)
 ;;=4^Incontinence of Feces
 ;;^UTILITY(U,$J,358.3,14071,1,5,0)
 ;;=5^787.60
 ;;^UTILITY(U,$J,358.3,14071,2)
 ;;=^339670
 ;;^UTILITY(U,$J,358.3,14072,0)
 ;;=780.64^^85^875^12
 ;;^UTILITY(U,$J,358.3,14072,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14072,1,4,0)
 ;;=4^Chills
 ;;^UTILITY(U,$J,358.3,14072,1,5,0)
 ;;=5^780.64
 ;;^UTILITY(U,$J,358.3,14072,2)
 ;;=^336670
 ;;^UTILITY(U,$J,358.3,14073,0)
 ;;=294.20^^85^875^17
 ;;^UTILITY(U,$J,358.3,14073,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14073,1,4,0)
 ;;=4^Dementia NOS
